Renhao Li
Impact in
- Pharmaceutical Science top 10%
- Advancements in Transdermal Drug Delivery
-
- Cancer Research and Treatments
Papers in
-
- Immunotherapy and Immune Responses 2
-
- SARS-CoV-2 and COVID-19 Research 2
- SARS-CoV-2 detection and testing 1
- Co-authors
- Bao‐Zhong Zhang (6 shared papers)Hua‐Rui Gong (6 shared papers)Jian‐Dong Huang (7 shared papers)Minwei Chai (1 shared paper)Guo Yu Qiu (1 shared paper)Fuchen Shi (1 shared paper)Jingchu Hu (4 shared papers)Rong Li (2 shared papers)
- Journals
- Nature Communications (2 papers)Advanced Materials Technologies (1 paper)EBioMedicine (1 paper)Proceedings of the National Academy of Sciences (1 paper)AIDS Research and Human Retroviruses (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Renhao Li
11 papers receiving 231 citations
Peers
Comparison fields: 5 of 61
- Pharmaceutical Science 29
- Biotechnology 39
- Immunology 54
- Pollution 20
- Infectious Diseases 24
Countries citing papers authored by Renhao Li
This map shows the geographic impact of Renhao Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renhao Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renhao Li more than expected).
Fields of papers citing papers by Renhao Li
This network shows the impact of papers produced by Renhao Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renhao Li. The network helps show where Renhao Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Renhao Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 79 | |
| 2 | 2013 | 41 | |
| 3 | 2022 | 37 | |
| 4 | 2023 | 21 | |
| 5 | 2021 | 15 | |
| 6 | 2011 | 14 | |
| 7 | 2012 | 9 | |
| 8 | 2025 | 6 | |
| 9 | 1999 | 5 | |
| 10 | 2024 | 4 | |
| 11 | 2023 | 2 |
About Renhao Li
Renhao Li is a scholar working on Immunology, Infectious Diseases, Molecular Biology, Genetics and Biotechnology, having authored 11 papers that have together received 233 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (2 papers), Cell Adhesion Molecules Research (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Infection Control and Ventilation (1 paper), Milk Quality and Mastitis in Dairy Cows (1 paper), RNA and protein synthesis mechanisms (1 paper), Heavy metals in environment (1 paper) and SARS-CoV-2 detection and testing (1 paper). The work is most often cited by research in Pharmaceutical Science (29 citations), Biotechnology (39 citations), Immunology (54 citations), Pollution (20 citations) and Infectious Diseases (24 citations). Renhao Li has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Bao‐Zhong Zhang, Hua‐Rui Gong, Jian‐Dong Huang, Minwei Chai, Guo Yu Qiu, Fuchen Shi, Jingchu Hu, Rong Li, Bin Yu and Chenjie Xu. Their work appears in journals such as Nature Communications, Advanced Materials Technologies, EBioMedicine, Proceedings of the National Academy of Sciences and AIDS Research and Human Retroviruses.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.